SA
Log In
AZN
OverviewIntelligenceChart
Next earnings: Jul 27, 2026 · Before open
Signal
Mixed1↑1↓
Price
1↑
Move↑+1.17%Positive session
Volume
1→
Volume→1.1× avgNormal activity
Technical
1↓
RSI↓RSI 45Momentum negative
PRICE
Prev Close
185.20
Open
188.47
Day Range186.87 – 190.00
186.87
190.00
52W Range132.32 – 212.71
132.32
212.71
68% of range
VOLUME & SIZE
Avg Volume
2.2M
FUNDAMENTALS
P/E Ratio
28.2x
EPS (TTM)
—
Div Yield
0.02%
Beta
0.53
Low vol
Performance
1D
+1.17%
5D
-0.94%
1M↓
-3.36%
3M
+0.14%
6M
+13.78%
YTD
+6.76%
1Y↑
+28.65%
Best: 1Y (+28.65%)Worst: 1M (-3.36%)
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev -18% · 80% gross margin
Valuation
EXPENSIVE
P/E 28x vs ~20x sector
Health
MODERATE
CR 0.9 (low) · FCF $5.67/sh
Neutral
Key MetricsTTM
Market Cap$294.28B
Revenue TTM$45.15B
Net Income TTM$11.55B
Free Cash Flow$10.57B
Gross Margin79.7%
Net Margin17.2%
Operating Margin23.5%
Return on Equity22.4%
Return on Assets9.2%
Debt / Equity0.72
Current Ratio0.91
EPS TTM$6.75
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong1 watch2 concern
54/100
Liquidity
0.91Concern
Leverage
0.72Strong
Coverage
8.5xStrong
ROE
22.4%Strong
ROIC
12.9%Watch
Cash
$5.7BConcern
ANALYST COVERAGE39 analysts
HOLD
▲ +12.6%upside to target
L $206.00
Med $211.00consensus
H $216.00
Buy
1949%
Hold
1538%
Sell
513%
19 Buy (49%)15 Hold (38%)5 Sell (13%)
Full report →
Stock Health
Composite Score
1 of 5 signals bullish
4/10
Technicals
●
RSI RangeRSI 45 — Bearish momentum
✗
Volume
●
Volume FlowNeutral
~
Fundamentals
●
Last EarningsBeat estimates
✓
●
Analyst ConsensusHold
~
●
LiquidityCurrent Ratio 0.91 — liquidity risk
✗
Upcoming Events
EEarnings ReportMay 2, 2026
Tomorrow
DEx-Dividend DateJul 30, 2026
In 90 days
PDividend PaymentOct 20, 2026
In 172 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBEARISH
Technicals →

Trend

→ PullbackGolden Cross · 50D leads 200D by 33.8%

-3.0% vs SMA 50 · +29.8% vs SMA 200

Momentum

RSI45.1
Neutral territory
MACD-2.23
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$212.7+13.5%
Current
$187.4
EMA 50
$184.5-1.5%
EMA 200
$154.2-17.7%
52W Low
$132.3-29.4%
52-Week RangeMid-range
$132.368th %ile$212.7
Squeeze SetupVolume-based
No Clear Setup

Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.

20-Day Money Flow
Acc days:1
Dist days:2
Edge:+1 dist
Volume Context
Avg Vol (50D)2.1M
Recent Vol (5D)
1.7M-23%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 18 analysts
Full estimates →
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$58.6B
$57.4B–$59.4B
—$9.16—
±3%
High17
FY2026(current)
$63.4B
$62.3B–$64.3B
▲ +8.0%$10.27▲ +12.1%
±1%
High17
FY2027
$67.8B
$64.6B–$69.3B
▲ +7.0%$11.61▲ +13.1%
±4%
High18
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryAZN
Last 8Q
+2.4%avg beat
Beat 7 of 8 quartersMissed 1↑ Estimates rising
+1%
Q3'24
+2%
Q4'24
+1%
Q1'25
+10%
Q2'25
+1%
Q3'25
+4%
Q4'25
-3%
Q1'26
+3%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
Deutsche BankSell → Hold
Sep 13
DOWNGRADE
Deutsche BankHold → Sell
Sep 12
DOWNGRADE
NordeaSell
Sep 11
DOWNGRADE
Deutsche BankHold
Apr 16
UPGRADE
JefferiesBuy
Sep 25
UPGRADE
Financials
Dividends1.69% yield
+144.2% avg annual growth
Annual Yield1.69%
Semi-Annual Div.$2.1700
Est. Annual / Share$4.34
FrequencySemi-Annual
Q3'22
Q1'23
Q3'23
Q1'24
Q3'24
Q1'25
Q3'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
Pictet Asset Management Holding SA
3.5M▲
2
Swedbank AB
2.5M▼
3
ABN AMRO Bank N.V.
2.4M▲
4
Lansforsakringar Fondforvaltning AB (publ)
2.4M▲
5
Border to Coast Pensions Partnership Ltd
2.0M▲
6
Ninety One UK Ltd
2.0M▲
7
LGT Group Foundation
1.9M▲
8
Artemis Investment Management LLP
1.4M▲
News & Activity

AZN News

20 articles · 4h ago

About

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Pascal Soriot
Country
United Kingdom
Website
astrazeneca.com ↗
Iskra ReicExecutive Vice President of International
Ruth MarchSenior Vice President of Precision Medicine - R&D Oncology
Susan Mary GalbraithExecutive Vice President of Oncology R&D
Peers— —(7 companies)
Screen sector →
SymbolPriceDay %Mkt Cap↓P/ERev GrwMarginELO
AZN◀
$187.37+1.17%$290.5B28.1+862.9%1745.9%1500
TSM
$396.06+0.57%$2.1T28.7+3296.8%4510.0%1500
HSBC
$91.86+2.89%$318.3B14.0+318.8%1510.7%1500
BABA
$131.91+1.13%$306.2B22.6+586.3%1305.9%1500
NVS
$147.85+3.44%$282.1B21.0+597.3%2564.4%1500
SHEL
$90.67+1.98%$256.7B14.5-591.0%668.4%1500
RY
$179.97+2.71%$251.3B16.3+213.3%1482.4%1500
Sector avg—+1.98%—20.7+754.9%1969.6%1500

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance